Among the enrolled patients, 17 (17/99, 17.2%) received PD-1 inhibitors at the initial diagnosis of HCC and 82 patients had at least one previous HCC treatment including transarterial chemoembolization (TACE), radiofrequency ablation (RFA), surgical resection, or radiotherapy. Here, PDCD1 is linked to hepatocellular carcinoma.